Effect of felodipine on arterial blood flow and venous function at rest in patients with mild essential hypertension

Angiology

Volumn 49, Issue 5, 1998, Pages 373-380

  Bicchi, Maurizio ^a,b   Vedovini, Giovanni ^a   Cappelli, Roberto ^a   Arrigucci, Stefano ^a   Righi, Giovanni Andrea ^a   Forconi, Sandro ^a  

^a University of Siena ^*

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FELODIPINE;

ADULT; AGED; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; CALCIUM ANTAGONISM; CLINICAL ARTICLE; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FEMALE; HEART RATE; HISTOGRAM; HUMAN; HUMAN CELL; HUMAN TISSUE; LIMB BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; PLETHYSMOGRAPHY;

EID: 0031808119     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979804900506     Document Type: Article

References (18)

1. Bossini A, Di Veroni C, Cavallotti G, et al: Felodipine ER formulation in the treatment of mild hypertension: Efficacy and tolerability vs placebo, Br J Clin Pharmacol 30:367-371,1990.
2. Blychert E, Frisen M, Karlsson O, et al: Twenty-four hour blood-pressure profiles in hypertensive patients following various formulations and dosage regimens of felodipine. Eur J Clin Pharmacol 42:25-30, 1992.
3. Dunlay MC, Lipschutz KH, Nelson EB, et al: Felodipine Study Group. A multicenter study of felodipine ER and placebo in elderly and young hypertensive patients (Abstract). Am J Hypertens 4:25A, 1991.
4. Little WC, Cheng C-P: Vascular vs myocardial effects of calcium antagonists (Abstract). Fifth International Symposium on Calcium Antagonists: Pharmacology and Clinical Research. Houston, Sept 25-28,1991.
5. Nordlander M, DiBona GF, Ljung B, et al: In vivo/in vitro evaluation of vascular/myocardial selectivity of felodipine and amlodipine (Abstract). 74,12. Second International Symposium. Calcium Antagonists in Cardiovascular Care. Basel, Feb 13-15,1991.
6. Hermsmeyer K, Rusch NJ: Felodipine actions on vascular muscle Ca2+ channels. J Cardiovasc Pharmacol 10 (suppl l):540-543, 1987.
7. Ljung B: Vascular selectivity of felodipine. Drugs 29: 46-58,1985.
8. Bostrom SL, Ljung B, Mardh S, et al: Interaction of the antihypertensive drug felodipine with calmodulin. Nature 292:777-778, 1981.
9. Blychert E, Hedner T, Dahlof C, et al: Plasma concentration-effect relationships of intravenous and extended-release oral felodipine in hypertensive patients. J Cardiovasc Pharmacol 15:428-435,1990.
10. Leonetti G, Gradnik R, Terzoli L, et al: Effects of single and repeated doses of the calcium-antagonist felodipine on blood pressure, renal function, electrolytes and water balance, and the renin-angiotensin-aldosterone system in hypertensive patients. J Cardiovasc Pharmacol 8:1243-1248, 1986.
11. Kaseda N, Hayasaki K, Honda T, et al: Antianginal, hemodynamic and coronary vascular effects of felodipine in stable angina pectoris (Abstract). Jap Cire J 55 (suppl A):377,1991.
12. Pucci PD, et al: Acute effects on exercise tolerance of felodipine and diltiazem, alone and in combination, in stable effort angina. Eur Heart J 12:55-59,1991.
13. Forconi S, Jageneau A, Guerrini M, et al: Strain gauge plethysmography in the study of the circulation of the limbs. Angiology 30:487-497,1979.
14. Coffman JD, Lempert JA: Venous flow velocity, venous volume and arterial blood flow. Circulation 52:141-143, 1975.
15. Hulten LU, Katzman PL: Renal effects of acute and long-term treatment with felodipine in essential hypertension. Hypertension 6:231-237,1988.
16. Herlitz H, Aurell M, Biorch S, et al: Renal effects of felodipine in hypertensive patients with reduced renal function. Drugs 29 (suppl 2):192-197,1985.
17. Fariello R, Boni E, Corda L, et al: Extended release felodipine in essential hypertension. Am J Hypertens 4:27-33, 1991.
18. Muir AL, Nolan J: Modulation of venous tone in heart failure. Am Heart J 121:1948-1950, 1991.